Article and Video CATEGORIES

Cancer Journey

Search By

What Are Your Current Practices for Consolidation Chest Radiation for Extensive SCLC?
Sun, 12/13/2015 - 06:00
GRACE Videos and Articles



Drs. Leora Horn, Ben Solomon, & Jack West debate whether results from a European trial of chest radiation after chemotherapy for extensive stage small cell lung cancer should lead to a change in treatment for this setting.


Download Transcript

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.



Dr. West:  Not a lot here on small cell lung cancer, but there are still a couple of pretty controversial questions, including what the role is for consolidation chest radiation in patients who have residual chest disease after a good, but incomplete, response to chemotherapy. What are you guys doing in that situation? Is this something that has become a standard, or something that you often recommend, or at least discuss with patients, or is it still not something that has penetrated into common practice; Ben?

Dr. Solomon:  Yeah, so I must admit, even prior to the results with the Slotman study, which was published in the New England Journal — or, no, it was presented at ASCO — about thoracic radiation after chemotherapy, I used to worry about patients who had residual disease in their chest, because you worry that that’s a site at which they’re going to progress, and we’ve had discussions with our radiation oncology colleagues about treating that, almost preemptively. I think those data provide support to that, and provide an argument for delivering consolidation radiotherapy, if you like, for patients who have residual disease in their chest. There is additional toxicity from the treatment — the patients are pretty bashed up after their chemotherapy, so I think it’s a sort of individual discussion that we have with patients.

Dr. West:  And your thoughts?

Dr. Horn:  So, were doing the same. In the patients who tolerated chemotherapy well, and are doing well after chemotherapy, and had either bulky disease, or have residual disease, we will send them to discuss the thoracic radiation with the radiation oncology folks.

Next Previous link

Previous PostNext Post

Related Content

Mandarin LCVL
王林医生用普通话讨论重要的肺癌信息。这些信息包括靶向治疗、晚期疾病的症状、循环肿瘤 DNA、治疗方案等。我们鼓励您与社区中说普通话的人分享。 Dr. Lin Wang discusses important lung cancer information in Mandarin. This information includes targeted therapy, symptoms of advanced disease, circulating tumor DNA, treatment options, and more. We encourage you to share this with the Mandarin speakers in your community. To watch the complete Playlist visit:…;  
Tell your story!  Apply now for the Clinical Trials Experiences through Storytelling Program
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now!     GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview  
Blood Cancer OncTalk
Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.

Forum Discussions

Hi Caregiver and welcome to Grace.  I'm sorry that you need to be here and hope we can help.  Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...

Hi Bob, Welcome to Grace.  I'm sorry about your sil.  Unfortunately, cancer becomes resistant to TKIs like tagrisso.  Sometimes all of the cancer becomes resistant at once and sometimes just parts...

Recent Comments

Hi Tammy,  Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
By Tndiuka10 on Fri, 05/12/2023 - 21:13
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
Hi Bob, Welcome to Grace.  I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29